InvestorsHub Logo
Followers 4
Posts 88
Boards Moderated 0
Alias Born 12/12/2014

Re: None

Tuesday, 09/29/2015 7:26:28 AM

Tuesday, September 29, 2015 7:26:28 AM

Post# of 703792
Verastem yesterday.

Somehow interesting yesterday. Verastem announced enrollment stop in a phase II trial (VS-6063). Just some days before, they had a poster presentation at ESMO in Vienna about this product.

They stopped enollment for futility after an Interim Analysis by DSMB.

Link

I'm just hoping, something like that will not happen to NWBO.

Positive aspect of this incident is, that the temporarily stop of enrollment in the L-trial may have another cause. If there had been a DSMB-recommendation for stopping because of futility, then they wouldn't need to gather information for regulatory review as they are doing now. (Or am I wrong with this conclusion?)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News